Company Announcements ATLAS Biolabs GmbH joined Roche NimbleGen’s certified service program for targeted enrichment. In February, RainDance Technologies named S. Roopom Banerjee president and CEO. Recently, he was director of Healthcare Investment Banking at Leerink Swann. Former CEO Christopher McNary now serves as COO. RainDance Technologies partnered with Ambry Genetics for sequence enrichment and targeted […]
Company Announcements ZyGEM opened a European support office in Bemmel, the Netherlands. Innova Biosciences appointed Genetimes Technology and NeoBioscience Technology as Chinese distributors. In March, Polyplus-transfection SA signed an agreement with metabion GmbH to manufacture and commercialize its Zip Nucleic Acid oligonucleotides for research and in vitro diagnostics applications. Lonza Cologne AG will exclusively distribute […]
In February, SEAL Analytical, a Porvair company, introduced the AQ1 Discrete Analyzer. Discrete analyzers measure the alkalinity, as well as chloride and nitrate content of a sample, among other analytes, in individual reactions using automated colorimetric analysis. This is particularly relevant to the environmental market for applications such as nutrient, water and wastewater analysis. Discrete […]
Company Announcements Thermo Fisher Scientific will add 104 jobs over three years to its Asheville, North Carolina facility, which manufactures cold-storage equipment, centrifuges and ovens. Gerresheimer’s Life Science Research reported 2009 sales declined 5.8% to €87.4 million ($121.4 million), and fell 11.9% excluding currency effects, to make up 9% of revenue. Adjusted EBITDA fell 27.4% […]
There are more than 50 countries in Africa, yet the region’s research output remains disproportionately low. According to an analysis of research papers in Thomson Reuters’ Web of Sciences database published between 1999 and 2008, Africa’s north region (five countries) accounted for the greatest portion of the continent’s scientific output, publishing 10,500 papers in 2008. […]
The RAPEX 2009 Annual Report details non-food consumer-product safety notifications. The RAPEX system enables EU member states to share information about dangerous products. The number of measures taken and notifications about dangerous products rose 7% in 2009 to 1,993. The highest number of notifications were issued for toys (28% of notifications), and clothing and textiles […]
According to a survey conducted earlier this year by biotechnologie.de for the Federal Ministry of Education and Research, in 2009, there were 531 firms “occupied primarily with biotech” in Germany, a 6.0% increase. The number of employees at these companies grew 3.5% to 14,950. However, revenues declined 0.3% to €2,184 million ($2,914 million), and R&D […]
In aggregate, US, European, Canadian and Australian biotech companies recorded a $3.7 billion net profit in 2009, making it the first profitable year for the industry. However, raising capital remained difficult, with a few established companies gaining the bulk of new capital. Capital raised by US biotech firms rose 39% to $18.0 billion. Revenues for […]
Industrial emissions in the US are not being accurately recorded due to outdated monitoring equipment. Although recommendations have been made to the EPA to adopt more advanced monitoring equipment, such as the types used in Europe, the EPA has no plans to implement them. A 2006 report by the EPA inspector general found that emissions […]
IMS Healthcare Insight is maintaining its forecast of 4%–6% growth in pharmaceutical sales this year. Slower growth due to patent expirations and government cost mandates will be offset by growth in emerging markets. Over the next five years, patents will expire for products with sales of more than $142 billion. Drug sales are forecasted to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
